Industry resources and insights

Sort by year

All time
2025
2024
2023
2022
2021
2020
2019 and older

Articles

03.11.2025

Designing Payer-Ready Trials in 2025: Five Decisio...

Clinical innovation has never moved faster. Tools like single-arm designs, novel surrogates, and ada...

Articles

21.10.2025

Comparator Choice: The Question That Defines Marke...

Every payer ultimately asks the same question: “Compared with what?” This single question shapes...

Poster

15.10.2025

How the EU JCA could interface with Regional Prici...

Objectives: To analyse how the mandatory EU Joint Clinical Assessment (JCA) could in...

Poster

15.10.2025

Budget impact minimisation approaches used across ...

Objectives: The market entry of effective obesity medications offers promise to patients with obesit...

Articles

13.10.2025

Surrogates Under Scrutiny: Proving the Link to Out...

Surrogate Endpoints in HTA Decision-Making The need to stay ahead of competitors and offset losses f...

Webinar

08.10.2025

Navigating NICE’s HST Pathway: Insights from Bot...

NICE’s Highly Specialised Technologies (HST) Programme offers a vital route for bringing ultra-rar...

Load more

Browse by topic

Advanced Therapy Medicinal Products
Alzheimer’s
BD Assessments
Biosimilars
Biotech
Devices & Diagnostics
Digital Health
Early Access
Early Payer Dialogue
Emerging & Developing Markets
Funding
Gene Therapy & ATMPs
HTA
International Reference Pricing
ISPOR
Launch
Managed Entry Agreements
Medicine manufacturing
MFN
NICE
Oncology
Orphan Drugs
PMA Trends
Pricing
Rare Diseases
Real World Evidence
Team Remap
Tendering & Procurement
Training
United States

Content type

All
Articles
Case Studies
Checklist
Guide
Insider Insights
News
Poster
Publications
Webinar

Subscribe